The use of pegvisomant in the complex treatment of acromegaly. Cases from practice
AbstractThe paper discusses rational schemes of pharmacotherapy for acromegaly and the place of pegvisomant in the complex drug treatment of patients with aggressive disease. The first domestic results of the use of pegvisomant, as well as cases from the clinical practice of pharmacotherapy of acromegaly, are presented.
Keywords:acromegaly, pituitary adenoma, drug therapy, growth hormone receptor antagonist, pegvisomant, analogues of somatostatin
Funding. The study had no sponsor support.
Conflict of interest. The authors declare no conflict of interest.
For citation: Pronin E.V., Antsiferov M.B., Alekseeva T.M. The use of pegvisomant in the complex treatment of acromegaly. Cases from practice. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2021; 10 (2): 167-9. DOI: https://doi.org/10.33029/2304-9529-2021-10-2-167-169 (in Russian)